Amarin Narrows Losses
Posted on August 09, 2012 at 14:13 PM EDT
Amarin Corp. (Nasdaq: AMRN) narrowed second quarter losses to 38 cents per share from $1.58 per share a year earlier and affirmed the commercial launch of its recently approved hypertriglyceridemia treatment Vascepa in the first quarter of 2013. Shares of the biopharmaceutical surged $1.97 to $13.31.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here